Mechanistic approaches to ochratoxin toxicity

Food Additives and Contaminants

Volumn 13, Issue SUPPL., 1996, Pages 45-48

  Dirheimer, G ^a  

^a INST DE BIOL MOLEC ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOTOXIN; OCHRATOXIN;

CONFERENCE PAPER; DNA ADDUCT; GENOTOXICITY; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA SYNTHESIS; TOXICOKINETICS; URINARY TRACT TUMOR;

DNA ADDUCTS; ENZYME INHIBITORS; LIPID PEROXIDATION; MUTAGENS; MYCOTOXINS; OCHRATOXINS;

EID: 0030462649     PISSN: 0265203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. CREPPY, E. E., STØRMER, F. C., RÖSCHENTHALER, R., and DIRHEIMER, G., 1983a, Effects of two metabolites of ochratoxin A, [4R]-4-hydroxyochratoxin A and ochratoxin α, on the immune response in mice. Infection and Immunity, 39, 1015-1018.
2. CREPPY, E. E., KERN, D., STEYN, P. S., VLEGGAAR, R., RÖSCHENTHALER, R., and DIRHEIMER, G., 1983b, Comparative study of the effect of ochratoxin A analogues on yeast aminoacyl-tRNA synthetases and on growth and protein synthesis in hepatoma cells. Toxicology Letters, 19, 217-224.
3. CREPPY, E. E., KANE, A., DIRHEIMER, G., LAGARGE-FRAYSSINET, C., MOUSSET, F., and FRAYSSINET, C., 1985, Genotoxicity of ochratoxin A in mice: DNA single-strand break evaluation in spleen, liver and kidney. Toxicology Letters, 28, 29-35.
4. CREPPY, E. E., KANE, A., GIESEN-CROUSE, E., ROTH, A., RÖSCHENTHALER, R., and DIRHEIMER, G., 1986, Changes in urinary and renal tubular enzymes caused by subchronic administration of ochratoxin A in rats. Toxicology, 42, 233-243.
5. CREPPY, E. E., CHAKOR, K., FISCHER, M. J., and DIRHEIMER, G., 1990, The mycotoxin ochratoxin A is a substrate for phenylalanine hydroxylase in isolated rat hepatocytes and in vivo. Archives of Toxicology, 64, 279-284.
6. DEGEN, G., GERBER, M. M., OBRECHT, S., PFOHL-LESZKOWICZ, A., and DIRHEIMER, G., 1994, Genotoxicity and cytotoxicity of ochratoxin A in ovine seminal vesicle cells cultures. Frühjahrstagung der Deutschen Gemeinschaft Pharmakologie und Toxikologie., Mainz, Germany.
7. DIRHEIMER, G., and CREPPY, E. E., 1991, Mechanism of action of ochratoxin A. Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, edited by M. Castegnaro, R. Plestina, G. Dirheimer, I. N. Chernozemsky and H. Bartsch, IARC Scientific Publication No. 115 (Lyon: IARC), pp. 171-186.
8. FÖLLMANN, W., HILLEBRAND, I. E., CREPPY, E. E., and BOLT, H. M., 1995, Sister chromatid exchange frequency in cultured isolated porcine urinary bladder epithelial cells (PUBEC) treated with ochratoxin A and alpha. Archives of Toxicology, 69, 280-286.
9. HAUBECK, H. D., LORKOWSKI, G., KÖLSCH, E., and RÖSCHENTHALER, R., 1981, Immunosuppression by ochratoxin A and its prevention by phenylalanine. Applied and Environmental Microbiology, 41, 1040-1042.
10. HENNIG, A., FINK-GREMMELS, J., and LEISTNER, L., 1991, Mutagenicity and effects of ochratoxin A on the frequency of sister chromatid exchange after metabolic activation. In Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours edited by M. Castegnaro, R. Plestina, G. Dirheimer, I. N. Chernozemsky and H. Bartsch, IARC Scientific Publication No. 115 (Lyon: IARC), pp. 255-260.
11. IARC, 1993, Ochratoxin A. IARC Monograph on the Evaluation of Carcinogenic Risks to Humans. Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins, Vol. 56 (Lyon: IARC) pp. 489-521.
12. KANE, A., CREPPY, E. E., ROTH, A., RÖSCHENTHALER, R., and DIRHEIMER, G., 1986, Distribution of the [3H]-label from low doses of radioactive ochratoxin A ingested by rats, and evidence for DNA single-strand breaks caused in liver and kidneys. Archives of Toxicology, 58, 219-224.
13. KUIPER-GOODMAN, T., and SCOTT, P. M., 1989, Risk of the mycotoxin ochratoxin A. Biomedical and Environmental Science, 2, 179-248.
14. MANOLOVA, Y., MANOLOV, G., PARVANOVA, L., PETKOVA-BOCHAROVA, T., CASTEGNARO, M., and CHERNOZEMSKY, I. N., 1990, Induction of characteristic chromosomal aberrations, particularly X-trisomy, in cultured human lymphocytes treated by ochratoxin A, a mycotoxin implicated in Balkan endemic nephropathy. Mutation Research, 231, 143-149.
15. MAYURA, K., PARKER, R., BERNDT, W. O., and PHILIPPS, T. D., 1984, Ochratoxin A-induced teratogenesis in rats: partial protection by phenylalanine. Applied and Environmental Microbiology, 48, 1186-1188.
16. MEISSNER, H., and SELANIK, P., 1979, Inhibition of renal gluconeogenesis in rats by ochratoxin. Biochemical Journal, 180, 681-684.
17. MEISSNER, H., and MEISSNER, P., 1981, Ochratoxin A, in vivo inhibitor of renal phosphoenolpyruvate carboxykinase. Archives of Biochemistry and Biophysics, 208, 146-153.
18. MEISSNER, H., CIMBALA, M. A., and HANSON, R. W., 1983, Decrease of renal phosphoenolpyruvate carboxykinase RNA and poly(A) + RNA level by ochratoxin A. Archives of Biochemistry and Biophysics, 223, 264-270.
19. OBRECHT-PFLUMIO, S., GROSSE, Y., PFOHL-LESZKOWICZ, A., and DIRHEIMER, G., 1996, Protection by indomethacin and aspirin against genotoxicity of ochratoxin A, particularly in the urinary bladder and kidney. Archives of Toxicology, 70, 244-248.
20. OMAR, R. F., HASINOFF, B. B., MEJILLA, F., and RAHIMTULA, A. D., 1990, Mechanism of ochratoxin A stimulated lipid peroxidation. Biochemical Pharmacology, 40, 1183-1191.
21. OMAR, R. F., RAHIMTULA, A. D., and BARTSCH, H., 1991, Role of cytochrome P-450 in ochratoxin A-stimulated lipid peroxidation. Journal of Biochemical Toxicology, 6, 203-209.
22. PFOHL-LESZKOWICZ, A., 1994, L'ochratoxine A, mycotoxine ubiquitaire contaminant l'alimentation humaine. Comptes Rendus Société de Biologie, 188, 339-353 (in French).
23. PFOHL-LESZKOWICZ, A., CHAKOR, K., CREPPY, E. E., and DIRHEIMER, G., 1991, DNA adduct formation in mice treated with ochratoxin A. Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, edited by M. Castegnaro, R. Plestina, G. Dirheimer, I. N. Chernozemsky and H. Bartsch, IARC Scientific Publications No. 115 (Lyon: IARC), pp. 245-253.
24. PFOHL-LESZKOWICZ, A., GROSSE, Y., KANE, A., CREPPY, E. E., and DIRHEIMER, G., 1993a, Differential DNA adduct formation and disappearance in three mice tissues after treatment by the mycotoxin ochratoxin A. Mutation Research, 289, 265-273.
25. PFOHL-LESZKOWICZ, A., GROSSE, Y., KANE, A., CASTEGNARO, M., CREPPY, E. E., and DIRHEIMER, G., 1993b, Preponderance of DNA-adducts in kidney after ochratoxin A exposure. Human Ochratoxicosis and its Pathologies, edited by E. E. Creppy, M. Castegnaro and G. Dirheimer. Eurotext No. 231 (Montrouge, France: John Libbey), pp. 199-207.
26. PFOHL-LESZKOWICZ, A., GROSSE, Y., CASTEGNARO, M., NICOLOV, I. G., CHERNOZEMSKI, I. N., BARTSCH, H., BETBEDER, A. M., CREPPY, E. E., and DIRHEIMER, G., 1993c, Ochratoxin A-related DNA adducts in urinary tract tumours of Bulgarian subjects. Postlabelling Methods for Detection of DNA Adducts, edited by D. H. Phillips, M. Castegnaro and H. Bartsch, IARC Scientific Publication No. 124 (Lyon: IARC) pp. 141-148.
27. RAHIMTULA, A. D., BéRéZIAT, J. C., BUSSACCHINI-GRIOT, V., and BARTSCH, J., 1988, Lipid peroxidation as a possible cause of ochratoxin A toxicity. Biochemical Pharmacology, 4469-4477.
28. ROTH, A., CREPPY, E. E., KANE, A., BACHA, H., STEYN, P. S., RÖSCHENTHALER, R., and DIRHEIMER, G., 1989, Influence of ochratoxin B on the ochratoxin A inhibition of phenylalanyl-tRNA formation in vitro and protein synthesis in hepatoma tissue culture cells. Toxicology Letters, 45, 307-314.